Page 187 - Programme book for The International Liver Congress 2015, EASL ILC 2015
P. 187
YI P0387 IDENTIFICATION OF OPTIMAL CUT-OFFS IN ALPHA- ePOSTERS
FETOPROTEIN AND THE “AFP SCORE” TO MAXIMISE
YI P0388 THE ACCURACY OF SELECTION OF LIVER TRANSPLANT
YI P0389 CANDIDATES WITH HEPATOCELLULAR CARCINOMA
YI P0390 Ian A. Rowe*, Emmanouil Tsochatzis, Meera Shah, Debashis Haldar,
Diarmaid Houlihan, Susan Davies, Edmund Godfrey, Shishir Shetty,
YI P0391 James O’Beirne, Hynek Mergental, Christophe Duvoux,
YI P0392 Andrew Burroughs, Matthew Hoare, Tahir Shah, The United Kingdom
YI P0521
SURGICAL RESECTION VERSUS RADIOFREQUENCY
ABLATION FOR SINGLE HEPATOCELLULAR CARCINOMA ≤
2 CM IN A PROPENSITY SCORE MODEL
Po-Hong Liu*, Cheng-Yuan Hsia, Chia-Yang Hsu,Yun-Hsuan Lee,Yi-
Hsiang Huang,Yi-You Chiou, Han-Chieh Lin, Teh-Ia Huo, Taiwan
CAN WE PREDICT MICROVASCULAR INVASION IN HCC ON
FDG PET-CT?
Vishal Agarwal*, India
BASELINE BILIRUBIN AND NOT CHILD-PUGH A OR B7
PREDICTS SURVIVAL OF BCLC B PATIENTS TREATED
WITH SORAFENIB. THE CLINICAL APPROACH TO THE
STRATIFICATION DEBATE
Alessia Gazzola*, Roberto Di Donato, Maria Reig, Neus Llarch,
Alejandro Forner, Anna Darnell, Jordi Rimola, Carmen Ayuso,
Jordi Bruix, Spain
PRIOR HISTORY OF ARTERIAL HYPERTENSION IS NOT A
CONTRAINDICATION TO SORAFENIB AND IS ASSOCIATED
TO A BETTER SURVIVAL IN PATIENTS WITH ADVANCED HCC
Roberto Di Donato*, Alessia Gazzola, Maria Reig, Ana Garcia Alvarez,
Evelyn Santiago, Ferran Torres, Alejandro Forner, Anna Darnell,
Carmen Ayuso, Jordi Bruix, Spain
TRANSARTERIAL CHEMOEMBOLISATION IN PATIENTS
WITH METASTATIC HEPATOCELLULAR CARCINOMA
Dominik Bettinger, Tobias Böttler*, Renan Spode, Robert Thimme,
Michael Schultheiß, Germany
CHARACTERIZATION AND VALIDATION OF ANGIOGENIC
GENETIC VARIANTS RELATED TO CHRONIC HEPATITIS C
PROGRESSION TO HEPATOCELLULAR CARCINOMA
Rosario López-Rodríguez *, María J. Borque-Iñurrita, Ángel Hernández-
Bartolomé,Yolanda Rodríguez-Muñoz, José R. Vidal-Castiñeira,
Luis Rodrigo, Javier García-Samaniego, Antonio Madejón,
Francisco Abad-Santos, José M. Ladero, Paloma Muñoz de Rueda,
Javier Salmerón, Ana Martín-Algíbez, Ana Aransay, Luisa García-
Buey, Jorge Mendoza,Yolanda Real, Leticia González-Moreno,
Ricardo Moreno-Otero, Paloma Sanz-Cameno, Spain
Vienna, Austria • April 22–26, 2015 187
FETOPROTEIN AND THE “AFP SCORE” TO MAXIMISE
YI P0388 THE ACCURACY OF SELECTION OF LIVER TRANSPLANT
YI P0389 CANDIDATES WITH HEPATOCELLULAR CARCINOMA
YI P0390 Ian A. Rowe*, Emmanouil Tsochatzis, Meera Shah, Debashis Haldar,
Diarmaid Houlihan, Susan Davies, Edmund Godfrey, Shishir Shetty,
YI P0391 James O’Beirne, Hynek Mergental, Christophe Duvoux,
YI P0392 Andrew Burroughs, Matthew Hoare, Tahir Shah, The United Kingdom
YI P0521
SURGICAL RESECTION VERSUS RADIOFREQUENCY
ABLATION FOR SINGLE HEPATOCELLULAR CARCINOMA ≤
2 CM IN A PROPENSITY SCORE MODEL
Po-Hong Liu*, Cheng-Yuan Hsia, Chia-Yang Hsu,Yun-Hsuan Lee,Yi-
Hsiang Huang,Yi-You Chiou, Han-Chieh Lin, Teh-Ia Huo, Taiwan
CAN WE PREDICT MICROVASCULAR INVASION IN HCC ON
FDG PET-CT?
Vishal Agarwal*, India
BASELINE BILIRUBIN AND NOT CHILD-PUGH A OR B7
PREDICTS SURVIVAL OF BCLC B PATIENTS TREATED
WITH SORAFENIB. THE CLINICAL APPROACH TO THE
STRATIFICATION DEBATE
Alessia Gazzola*, Roberto Di Donato, Maria Reig, Neus Llarch,
Alejandro Forner, Anna Darnell, Jordi Rimola, Carmen Ayuso,
Jordi Bruix, Spain
PRIOR HISTORY OF ARTERIAL HYPERTENSION IS NOT A
CONTRAINDICATION TO SORAFENIB AND IS ASSOCIATED
TO A BETTER SURVIVAL IN PATIENTS WITH ADVANCED HCC
Roberto Di Donato*, Alessia Gazzola, Maria Reig, Ana Garcia Alvarez,
Evelyn Santiago, Ferran Torres, Alejandro Forner, Anna Darnell,
Carmen Ayuso, Jordi Bruix, Spain
TRANSARTERIAL CHEMOEMBOLISATION IN PATIENTS
WITH METASTATIC HEPATOCELLULAR CARCINOMA
Dominik Bettinger, Tobias Böttler*, Renan Spode, Robert Thimme,
Michael Schultheiß, Germany
CHARACTERIZATION AND VALIDATION OF ANGIOGENIC
GENETIC VARIANTS RELATED TO CHRONIC HEPATITIS C
PROGRESSION TO HEPATOCELLULAR CARCINOMA
Rosario López-Rodríguez *, María J. Borque-Iñurrita, Ángel Hernández-
Bartolomé,Yolanda Rodríguez-Muñoz, José R. Vidal-Castiñeira,
Luis Rodrigo, Javier García-Samaniego, Antonio Madejón,
Francisco Abad-Santos, José M. Ladero, Paloma Muñoz de Rueda,
Javier Salmerón, Ana Martín-Algíbez, Ana Aransay, Luisa García-
Buey, Jorge Mendoza,Yolanda Real, Leticia González-Moreno,
Ricardo Moreno-Otero, Paloma Sanz-Cameno, Spain
Vienna, Austria • April 22–26, 2015 187
